About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

2.100 +0.080 (+3.96%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,757
Open 2.000
Bid (Size) 2.070 (100)
Ask (Size) 2.170 (400)
Prev. Close 2.020
Today's Range 1.990 - 2.109
52wk Range 1.960 - 54.00
Shares Outstanding 596,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Enveric Biosciences, Inc.
Via Business Wire

Performance

YTD
-42.8%
-42.8%
1 Month
-44.1%
-44.1%
3 Month
-61.5%
-61.5%
6 Month
-84.2%
-84.2%
1 Year
-88.9%
-88.9%

More News

Read More
Top movers analysis in the middle of the day on 2026-01-28: top gainers and losers in today's session. ↗
Via Chartmill
Why Did ENVB Stock More Than Double In Value Today? ↗
Via Stocktwits
Gapping stocks in Wednesday's session ↗
Via Chartmill
News headline image
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Why Is ENVB Stock Rising Today? ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Enveric Biosciences Announces Patent Issuance
From Enveric Biosciences
Via Business Wire
News headline image
The Great Migration: Why International Tech and Biotech Giants are Redomiciling to the Massachusetts Hub
Via MarketMinute
Topics Economy Initial Public Offering
News headline image
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Top movers analysis one hour before the close of the markets on 2025-12-11: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds
From Enveric Biosciences, Inc
Via Business Wire
News headline image
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Via Chartmill
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
Via Chartmill
News headline image
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates
From Enveric Biosciences
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results
From Enveric Biosciences
Via Business Wire
News headline image
Which stocks are moving on Monday? ↗
Via Chartmill
News headline image
Enveric Biosciences Announces Reverse Stock Split
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal
From Enveric Biosciences
Via Business Wire

Frequently Asked Questions

Is Enveric Biosciences, Inc. - Common Stock publicly traded?
Yes, Enveric Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Enveric Biosciences, Inc. - Common Stock trade on?
Enveric Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enveric Biosciences, Inc. - Common Stock?
The ticker symbol for Enveric Biosciences, Inc. - Common Stock is ENVB on the Nasdaq Stock Market
What is the current price of Enveric Biosciences, Inc. - Common Stock?
The current price of Enveric Biosciences, Inc. - Common Stock is 2.100
When was Enveric Biosciences, Inc. - Common Stock last traded?
The last trade of Enveric Biosciences, Inc. - Common Stock was at 02/13/26 04:00 PM ET
What is the market capitalization of Enveric Biosciences, Inc. - Common Stock?
The market capitalization of Enveric Biosciences, Inc. - Common Stock is 1.25M
How many shares of Enveric Biosciences, Inc. - Common Stock are outstanding?
Enveric Biosciences, Inc. - Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.